Archives for February 1, 2023

← 2023

Prothena: Trial data underscores the potential of antibody in treating Alzheimer’s disease

01-Feb-2023

By Jane Byrne

Biotechnology company, Prothena, has announced positive topline P1 SAD study results for PRX005, an investigational tri-epitopic antibody for the treatment of Alzheimer’s disease.

New US CDMO launched to address viral vector supply bottleneck

01-Feb-2023

By Jane Byrne

Vector BioMed, a CDMO specializing in the manufacture of lentiviral vectors, launched this week; its first financing round was led by Viking Global Investors and Casdin Capital.